Hutchmed (China)
HCM
Ermenegildo Zegna NV
ZGN
New Fortress Energy
NFE
Enerpac Tool
EPAC
eBay
EBAY
US Stock MarketDetailed Quotes
SYRE Spyre Therapeutics
- 20.620
- +0.070+0.34%
Close Jan 17 16:00 ET
- 20.620
- 0.0000.00%
Post 16:02 ET
1.24BMarket Cap-13.75P/E (TTM)
21.240High20.330Low607.58KVolume20.960Open20.550Pre Close12.56MTurnover1.29%Turnover RatioLossP/E (Static)60.30MShares47.97052wk High7.25P/B974.48MFloat Cap20.07052wk Low--Dividend TTM47.26MShs Float318.750Historical High--Div YieldTTM4.43%Amplitude2.650Historical Low20.667Avg Price1Lot Size
Spyre Therapeutics News
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burrows Scott L
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sloan Sheldon
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Turtle Cameron
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer King-Jones Heidy
Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENDERSON MICHAEL THOMAS
Spyre Therapeutics | 8-K: Current report
Spyre Therapeutics | 8-K: Current report
Spyre Therapeutics | 424B5: Prospectus
Spyre Therapeutics | 424B5: Prospectus
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)
Spyre Therapeutics | 10-K/A: Annual report (Amendment)
Spyre Therapeutics | 8-K: Current report
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(5.3%),VHCP Co-Investment Holdings III, LLC(5.3%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(5.7%),Joseph Edelman(5.7%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(3.9%),Commodore Capital Master LP(3.9%)
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(1.97%),Deep Track Biotechnology Master Fund, Ltd.(1.97%), etc.
Spyre Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(1.7%),Behzad Aghazadeh(1.7%)
Spyre Therapeutics | 8-K: Current report